New Delhi [India], Aug 18 (ANI): Electric mobility startup Zypp said on Tuesday it delivered over five lakh units in the past four months to enable its customers deliver essentials for their end-customers during the COVID-19 lockdown.
Ahmedabad (Gujarat) [India], Aug 13 (ANI): Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market.
Ahmedabad (Gujarat) [India], July 31 (ANI): Zydus Wellness said on Friday its net profit for the April to June quarter jumped by nearly 11 per cent at Rs 89 crore from Rs 80 crore in the corresponding quarter of previous year.
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
Ahmedabad (Gujarat) [India], July 15 (ANI): Pharmaceutical major Zydus on Wednesday started human clinical trials of its plasmid DNA vaccine ZyCoV-D -- a potential COVID-19 vaccine.
New Delhi [India], July 14 (ANI): Ayushmann Khurrana, who is known for creating a genre of his own in Bollywood, on Tuesday said that he has deliberately done films that do not have any reference points.
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
Ahmedabad (Gujarat) [India], July 3 (ANI): Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its vaccine technology centre here has successfully completed the pre-clinical phase.
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Adelaide [Australia], June 27 (ANI): In a breakthrough study, researchers discovered that a novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - can dramatically improve the quality of life for people suffering from prostate cancer.
Adelaide [Australia], June 22 (ANI): A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - can dramatically improve the quality of life for people suffering from prostate cancer.